| ICD-10-CM-2023 > Z00-Z99 > Z77-Z99 > Z79 |
Z77-Z99 | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | |
Use add'l | any follow-up examination (Z08-Z09) | |
Z79 | Long term (current) drug therapy | |
Incl.: | long term (current) drug use for prophylactic purposes | |
Use add'l | any therapeutic drug level monitoring (Z51.81) | |
Excl2.: | drug abuse and dependence (F11-F19) drug use complicating pregnancy, childbirth, and the puerperium (O99.32-) | |
Z79.0 | Long term (current) use of anticoagulants and antithrombotics/antiplatelets | |
Excl2.: | long term (current) use of aspirin (Z79.82) | |
Z79.01 | Long term (current) use of anticoagulants | |
Z79.02 | Long term (current) use of antithrombotics/antiplatelets | |
Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) | |
Excl2.: | long term (current) use of aspirin (Z79.82) | |
Z79.2 | Long term (current) use of antibiotics | |
Z79.3 | Long term (current) use of hormonal contraceptives | |
Info: | Long term (current) use of birth control pill or patch | |
Z79.4 | Long term (current) use of insulin | |
Excl2.: | long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85) long term (current) use of oral antidiabetic drugs (Z79.84) long term (current) use of oral hypoglycemic drugs (Z79.84) | |
Z79.5 | Long term (current) use of steroids | |
Z79.51 | Long term (current) use of inhaled steroids | |
Z79.52 | Long term (current) use of systemic steroids | |
Z79.6 | Long term (current) use of immunomodulators and immunosuppressants | |
Excl2.: | long term (current) use of steroids (Z79.5-) long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-) | |
Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants | |
Z79.61 | Long term (current) use of immunomodulator | |
Info: | Long term (current) use of apremilast Long term (current) use of immunomodulatory imide drug Long term (current) use of lenalidomide Long term (current) use of pomalidomide | |
Z79.62 | Long term (current) use of immunosuppressant | |
Z79.620 | Long term (current) use of immunosuppressive biologic | |
Info: | Long term (current) use of adalimumab Long term (current) use of etanercept Long term (current) use of infliximab Long term (current) use of monoclonal antibodies | |
Z79.621 | Long term (current) use of calcineurin inhibitor | |
Info: | Long term (current) use of cyclosporine Long term (current) use of tacrolimus | |
Z79.622 | Long term (current) use of Janus kinase inhibitor | |
Info: | Long term (current) use of tofacitinib | |
Z79.623 | Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor | |
Info: | Long term (current) use of sirolimus | |
Z79.624 | Long term (current) use of inhibitors of nucleotide synthesis | |
Info: | Long term (current) use of azathioprine Long term (current) use omycophenolate Long term (current) use of purine synthesis (IMDH) inhibitors | |
Z79.63 | Long term (current) use of chemotherapeutic agent | |
Z79.630 | Long term (current) use of alkylating agent | |
Info: | Long term (current) use of chlorambucil Long term (current) use of cisplatin Long term (current) use of cyclophosphamide | |
Z79.631 | Long term (current) use of antimetabolite agent | |
Info: | Long term (current) use of 5-fluorouracil Long term (current) use of 6-mercaptopurine Long term (current) use of cytarabine Long term (current) use of methotrexate | |
Z79.632 | Long term (current) use of antitumor antibiotic | |
Info: | Long term (current) use of bleomycin Long term (current) use of doxorubicin Long term (current) use of mitomycin C | |
Z79.633 | Long term (current) use of mitotic inhibitor | |
Info: | Long term (current) use of paclitaxel Long term (current) use of plant alkaloids Long term (current) use of vinblastine Long term (current) use of vincristine | |
Z79.634 | Long term (current) use of topoisomerase inhibitor | |
Info: | Long term (current) use of etoposide Long term (current) use of irinotecan Long term (current) use of topotecan | |
Z79.64 | Long term (current) use of myelosuppressive agent | |
Info: | Long term (current) use of hydroxyurea | |
Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants | |
Z79.8 | Other long term (current) drug therapy | |
Z79.81 | Long term (current) use of agents affecting estrogen receptors and estrogen levels | |
Code first | , if applicable: malignant neoplasm of breast (C50.-) malignant neoplasm of prostate (C61) | |
Use add'l | code, if applicable, to identify: estrogen receptor positive status (Z17.0) family history of breast cancer (Z80.3) genetic susceptibility to malignant neoplasm (cancer) (Z15.0-) personal history of breast cancer (Z85.3) personal history of prostate cancer (Z85.46) postmenopausal status (Z78.0) | |
Excl1.: | hormone replacement therapy (Z79.890) | |
Z79.810 | Long term (current) use of selective estrogen receptor modulators (SERMs) | |
Info: | Long term (current) use of raloxifene (Evista) Long term (current) use of tamoxifen (Nolvadex) Long term (current) use of toremifene (Fareston) | |
Z79.811 | Long term (current) use of aromatase inhibitors | |
Info: | Long term (current) use of anastrozole (Arimidex) Long term (current) use of exemestane (Aromasin) Long term (current) use of letrozole (Femara) | |
Z79.818 | Long term (current) use of other agents affecting estrogen receptors and estrogen levels | |
Info: | Long term (current) use of estrogen receptor downregulators Long term (current) use of fulvestrant (Faslodex) Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist Long term (current) use of goserelin acetate (Zoladex) Long term (current) use of leuprolide acetate (leuprorelin) (Lupron) Long term (current) use of megestrol acetate (Megace) | |
Z79.82 | Long term (current) use of aspirin | |
Z79.83 | Long term (current) use of bisphosphonates | |
Z79.84 | Long term (current) use of oral hypoglycemic drugs | |
Info: | Long term (current) use of oral antidiabetic drugs | |
Excl2.: | long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85) long term (current) use of insulin (Z79.4) | |
Z79.85 | Long-term (current) use of injectable non-insulin antidiabetic drugs | |
Excl2.: | long term (current) use of insulin (Z79.4) long term (current) use of oral hypoglycemic drugs (Z79.84) | |
Z79.89 | Other long term (current) drug therapy | |
Z79.890 | Hormone replacement therapy | |
Z79.891 | Long term (current) use of opiate analgesic | |
Info: | Long term (current) use of methadone for pain management | |
Excl1.: | methodone use NOS (F11.9-) use of methodone for treatment of heroin addiction (F11.2-) | |
Z79.899 | Other long term (current) drug therapy | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |